|
DKC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.232800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.185200E-01 |
| Normal-vs-Stage2 |
4.642200E-01 |
| Normal-vs-Stage3 |
1.694260E-02 |
| Normal-vs-Stage4 |
1.043950E-01 |
| Stage1-vs-Stage2 |
3.606600E-01 |
| Stage1-vs-Stage3 |
9.220100E-03 |
| Stage1-vs-Stage4 |
5.679500E-02 |
| Stage2-vs-Stage3 |
2.860000E-01 |
| Stage2-vs-Stage4 |
6.000200E-01 |
| Stage3-vs-Stage4 |
6.902000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.591600E-01 |
| Normal-vs-AfricanAmerican |
4.226000E-01 |
| Normal-vs-Asian |
1.067840E-01 |
| Caucasian-vs-AfricanAmerican |
7.326600E-01 |
| Caucasian-vs-Asian |
4.801700E-02 |
| AfricanAmerican-vs-Asian |
1.039970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.573200E-01 |
| Normal-vs-Female |
4.967400E-04 |
| Male-vs-Female |
7.60730000000098E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.762800E-01 |
| Normal-vs-Extreme_Weight |
5.143200E-01 |
| Normal-vs-Obese |
1.372790E-01 |
| Normal-vs-Extreme_Obese |
2.474000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.504600E-01 |
| Normal_Weight-vs-Obese |
5.471200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.715980E-02 |
| Extreme_Weight-vs-Obese |
5.428400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.872100E-02 |
| Obese-vs-Extreme_Obese |
2.702800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.018200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.653800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.533200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.536000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.107560E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.442400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.835700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.991220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.034200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.869000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.029600E-01 |
| Normal-VS-Type2 PRCC |
5.404600E-01 |
| Normal-VS-KIRP CIMP |
6.298400E-03 |
| Normal-VS-Unclassified PRCC |
3.129200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.916200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.099400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.858000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.34489999999532E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.005200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.990700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.963600E-01 |
| Normal-vs-N1 |
2.384000E-03 |
| Normal-vs-N2 |
4.333000E-01 |
| N0-vs-N1 |
1.376390E-03 |
| N0-vs-N2 |
7.015400E-01 |
| N1-vs-N2 |
3.018600E-01 |
|
|
